Jiayan Mao

749 total citations
29 papers, 601 citations indexed

About

Jiayan Mao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiayan Mao has authored 29 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiayan Mao's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (7 papers). Jiayan Mao is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and RNA modifications and cancer (7 papers). Jiayan Mao collaborates with scholars based in China, United States and Tunisia. Jiayan Mao's co-authors include Xiaoxiao Zheng, Wei Chen, Shufen Zhang, Ying Wu, Kequn Chai, Shangzhi Xie, Wei Chen, Liqiang Hu, Xuemei Lu and Xuning Shen and has published in prestigious journals such as Life Sciences, BioMed Research International and Journal of Cellular Biochemistry.

In The Last Decade

Jiayan Mao

28 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiayan Mao China	12	387	308	99	74	52	29	601
Yong Wei China	10	250 0.6×	178 0.6×	38 0.4×	31 0.4×	36 0.7×	31	407
Shiting Li China	13	424 1.1×	223 0.7×	106 1.1×	59 0.8×	166 3.2×	35	708
Pengping Li China	14	274 0.7×	198 0.6×	41 0.4×	118 1.6×	61 1.2×	43	510
Yanqing Wang China	15	249 0.6×	148 0.5×	17 0.2×	60 0.8×	61 1.2×	43	521
Xiangfu Chen China	16	454 1.2×	231 0.8×	31 0.3×	150 2.0×	103 2.0×	43	705
Pengcheng Dou China	13	241 0.6×	192 0.6×	28 0.3×	26 0.4×	24 0.5×	18	446
Zhen Yu China	13	148 0.4×	64 0.2×	58 0.6×	54 0.7×	57 1.1×	35	453
Wenjing Gong China	12	204 0.5×	173 0.6×	29 0.3×	48 0.6×	39 0.8×	36	359
Zeze Fu China	7	242 0.6×	88 0.3×	36 0.4×	166 2.2×	88 1.7×	12	537
Fengyi Mao United States	10	154 0.4×	99 0.3×	29 0.3×	38 0.5×	103 2.0×	17	399

Countries citing papers authored by Jiayan Mao

Since Specialization

Citations

This map shows the geographic impact of Jiayan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Mao more than expected).

Fields of papers citing papers by Jiayan Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Mao. The network helps show where Jiayan Mao may publish in the future.

Co-authorship network of co-authors of Jiayan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Mao. A scholar is included among the top collaborators of Jiayan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Mao. Jiayan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Enliang, Zhi-Ming Shao, Jiayan Mao, et al.. (2025). METTL3-mediated TUG1 regulation of miR-9 in doxorubicin resistance in HCC. Life Sciences. 378. 123832–123832.

Song, Jiangwei, Xiaobin Xu, Minjian Kong, et al.. (2024). Deptor protects against myocardial ischemia-reperfusion injury by regulating the mTOR signaling and autophagy. Cell Death Discovery. 10(1). 508–508. 5 indexed citations

Lu, Xuemei, Liqiang Hu, Jiayan Mao, et al.. (2023). Annexin A9 promotes cell proliferation by regulating the Wnt signaling pathway in colorectal cancer. Human Cell. 36(5). 1729–1740. 5 indexed citations

Mao, Jiayan, et al.. (2023). Application of DNA-based hydrogels as drug delivery system for immunomodulatory therapy. Journal of Drug Delivery Science and Technology. 86. 104677–104677. 5 indexed citations

Chen, Wei, et al.. (2023). Propofol mediates bone metastasis by regulating PC-derived exosomal miR-142-3p. Bulletin du Cancer. 110(3). 265–274. 1 indexed citations

He, Zhoukun, Na Wang, Zhuo Wang, et al.. (2023). Porous polydimethylsiloxane films with specific surface wettability but distinct regular physical structures fabricated by 3D printing. Frontiers in Bioengineering and Biotechnology. 11. 1272565–1272565. 4 indexed citations

Hu, Yue, Jing Shao, Shengchao Wang, et al.. (2022). Protection of adipose-derived mesenchymal stromal cells during acute lung injury requires autophagy maintained by mTOR. Cell Death Discovery. 8(1). 481–481. 8 indexed citations

Liu, Hao, Jian Ruan, Lingjie Wang, et al.. (2022). HOTAIR/miR-1277-5p/ZEB1 axis mediates hypoxia-induced oxaliplatin resistance via regulating epithelial-mesenchymal transition in colorectal cancer. Cell Death Discovery. 8(1). 310–310. 31 indexed citations

He, Zhoukun, Xiaorong Lan, Qinsheng Hu, et al.. (2021). Antifouling strategies based on super-phobic polymer materials. Progress in Organic Coatings. 157. 106285–106285. 61 indexed citations

10.

Deng, Fei, Daqing Hong, Wei Wang, et al.. (2021). The relationship between prescription of ultrafiltration and intradialytic hypotension in Chinese hemodialysis patients. Annals of Palliative Medicine. 10(5). 5316–5321. 2 indexed citations

11.

Xie, Juanjuan, et al.. (2020). CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway. Clinical & Translational Oncology. 23(2). 222–228. 36 indexed citations

12.

Chen, Jiabin, Shufen Zhang, Xiaoxiao Zheng, et al.. (2020). WZ4003 sensitizes non-small cell lung cancer cells to gefitinib via inhibition of ARK5 and epithelial-to-mesenchymal transition.. American Journal of Translational Research. 12(11). 7377–7385. 5 indexed citations

13.

Wang, Hui, Jiabin Chen, Shufen Zhang, et al.. (2020). MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer. Cancer Cell International. 20(1). 258–258. 40 indexed citations

14.

Shen, Xuning, Xiu Hu, Jiayan Mao, et al.. (2020). The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells. Cell Death and Disease. 11(1). 65–65. 74 indexed citations

15.

Wang, Juan, et al.. (2020). Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas. BioMed Research International. 2020(1). 5171242–5171242. 8 indexed citations

16.

Zhang, Wei, Xiaoxiao Zheng, Shangzhi Xie, et al.. (2020). TBOPP enhances the anticancer effect of cisplatin by inhibiting DOCK1 in renal cell carcinoma. Molecular Medicine Reports. 22(2). 1187–1194. 5 indexed citations

17.

Zhou, Yue, Jiayan Mao, Jian Shen, et al.. (2019). miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells. Cell Death and Disease. 10(11). 843–843. 88 indexed citations

18.

Wu, Ying, Shangzhi Xie, Xiaoxiao Zheng, et al.. (2019). Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer. Theranostics. 10(3). 1151–1165. 42 indexed citations

19.

Shen, Xuning, Honggang Jiang, Zhiheng Chen, et al.. (2019). <p>MicroRNA-145 Inhibits Cell Migration and Invasion in Colorectal Cancer by Targeting TWIST</p>. OncoTargets and Therapy. Volume 12. 10799–10809. 26 indexed citations

20.

Liu, Rongrong, Shangzhi Xie, Xiaoxiao Zheng, et al.. (2017). Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway. Anti-Cancer Drugs. 28(8). 861–868. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact